COVID-19 Response at Fishpond.com.au

Read what we're doing...

The Economics of New Health Technologies
By

Rating

Product Description
Product Details

Table of Contents

Part I. Introduction 1: Alistair McGuire & Victoria Serra: What do we know about the role of health care technology in driving healthcare expenditure growth? Part II. Innovation, diffusion and technology change 2: Davide Consoli, Andrew McMeekin, J. Stan Metcalfe, Andrea Mina & Ronnie Ramlogan: The process of innovation: incentives, behaviour and organization 3: Nick Bosanquet: Technology - scientific force or power force? 4: Victoria Serra-Sastre & Alistair McGuire: Diffusion of health technologies: evidence from the pharmaceutical sector Part III. Technological change and health insurance 5: Mark Pauly & Adam Isen: Insurance and new health technology 6: Peter Zweifel: Technological change and health insurance 7: Marin Gemmill, Victoria Serra & Joan Costa-Font: Health insurance and the uptake of new drugs in the United States 8: Lilia Filipova & Michael Hoy: Genetic advances and health insurance Part IV. Innovation, social demand and valuation 9: Roland Eisen & Yasemin Ilgin: Ageing and pharmaceutical innovation 10: Manuel Garcia-Goni & Paul Windrum: New approaches to healthcare innovation: information for chronic patients 11: Nicola Pangher: The convergence of nano-, bio- and information technologies in healthcare 12: Joshua Graff Zivin, Matthew Neidell, & Lauri Feldman: Treatment uncertainty and irreversibility in medical care: implications for cost-effectiveness analysis 13: Adam Oliver & Corinna Sorenson: The limits and challenges to the economic evaluation of health technologies Part V. Incentives, mechanisms and processes 14: Joan Rovira: Intellectual property rights and pharmaceuticals development 15: Frank R. Lichtenberg: Home, or nursing home? The effect of medical innovation on the demand for long-term care 16: Joan Costa-Font, Caroline Rudisill & Elias Mossialos: Demand for health information on the internet 17: Hristina Petkova: Institutional pathways for integrating genetic testing into mainstream healthcare

About the Author

Joan Costa-Font is a Senior Research Fellow and Lecturer at LSE. He teaches political economy, health economics and economic aspects of social policy at the London School of Economics and Political Science, and has previously taught Economics at the University of Barcelona. Dr Costa-Font is a fellow of CESifo (Munich), the health econometrics and data group (York), FEDEA (Madrid), IESE Business School and non-executive director of the Economics of Social Policy Unit (CAEPS) at the University of Barcelona. He has acted as an economic and research consultant for the Word Bank, the European Commission, the Spanish and Catalan governments as well as for private organisations. Christophe Courbage, is Director of the Health and Ageing and Insurance Economics research programmes at the Geneva Association. He lectures in Health Economics at the University of Lausanne, and "International Faculty" at the Singapore College of Insurance. Dr Courbage is also Deputy Editor of The Geneva Papers and Executive Secretary of the European Group of Risk and Insurance Economists (EGRIE). Dr Courbage was awarded the 1999 Ernst Meyer Prize by the Geneva Association for the best PhD thesis in Insurance Economics, is Deputy Editor of The Geneva Papers on Risk and Insurance - Issues and Practice, and is Executive Secretary of the European Group of Risk and Insurance Economists (EGRIE). Professor Alistair McGuire is a Professor in Health Economics at LSE Health and Social Care. He has been professor of Economic at City University and tought at Oxford University and Aberdeen. Professor McGuire has written numerous books, articles and reports in this area. He has also acted as an advisor to numerous UK government offices and research councils (including the ESRC and the MRC), as well as an economic consultant to a number of foreign governments, and domestic and foreign corporations and pharmaceutical companies. His current interests are in economic evaluation (especially when conducted alongside clinical trials), the economics of the hospital, technological diffusion, and health care insurance.

Ask a Question About this Product More...
Write your question below:
Look for similar items by category
People also searched for
How Fishpond Works
Fishpond works with suppliers all over the world to bring you a huge selection of products, really great prices, and delivery included on over 25 million products that we sell. We do our best every day to make Fishpond an awesome place for customers to shop and get what they want — all at the best prices online.
Webmasters, Bloggers & Website Owners
You can earn a 8% commission by selling The Economics of New Health Technologies: Incentives, organization, and financing on your website. It's easy to get started - we will give you example code. After you're set-up, your website can earn you money while you work, play or even sleep! You should start right now!
Authors / Publishers
Are you the Author or Publisher of a book? Or the manufacturer of one of the millions of products that we sell. You can improve sales and grow your revenue by submitting additional information on this title. The better the information we have about a product, the more we will sell!
Item ships from and is sold by Fishpond Retail Limited.
Back to top